GBI Bio

🚀 Exciting Partnership Announcement: Driving Innovation in Cancer Treatment 🚀 We are thrilled to announce a strategic collaboration between GBI Bio and Allterum Therapeutics, marking a major step forward in the fight against cancer. Together, we are combining our strengths to bring innovative, life-changing therapies to patients worldwide. Through this partnership, we will leverage our state-of-the-art facility and expert team to scale up the production of Allterum's breakthrough anti-cancer drug. This drug represents a new frontier in cancer treatment, offering hope to millions of patients affected by Acute Lymphoblastic Leukemia (ALL). This collaboration is not only a significant milestone for both companies, but it also highlights the power of partnerships in driving scientific progress and accelerating the availability of life-saving therapies. Key highlights of the collaboration 🤝: • Fast-tracked development and production to meet growing demand • Advanced technologies ensuring high-quality and efficient drug manufacturing • Shared commitment to innovation, quality, and patient outcomes Together, we are committed to making a difference in the lives of cancer patients everywhere. Stay tuned for more updates on this exciting journey & click the link below 👇 👇 to read the full Press Release ‼ https://lnkd.in/eNinVWU3 #CancerResearch #BiotechPartnership #CDMO #StrategicCollaboration #CancerTreatment #LifeSciences

GBI Bio’s recent pet drive collected over 150 pounds of pet food, along with toys, accessories, and essential items like cleaning supplies. These donations will support one of our local pet shelters - Saving Sage Animal Rescue, helping pets in need and making a meaningful difference. Staying involved in the community is important to GBI, and this drive is another step toward making a positive impact. #CommunitySupport #PetDrive #GBIBioCares #SavingSage #MakingADifference #Teamwork

Join GBI Bio's Director of BD Nicholas Filipancic, MBA at BioProcess International East in Boston, MA! 📍 Where to Find Us: Visit the Sip & Savour section located between aisles 1000 & 1100 or Poster Hall #103 💡 Why Stop By? - To Learn about how our tailored strategies can mitigate risks and streamline your path to market! Whether you’re looking to optimize your current processes, overcome specific challenges, or just want to explore new opportunities, our Director of BD is onsite ready to meet with you! If your booked up but want to set a virtual meeting with our team feel free to stop by & schedule a meeting with our Director of BD or click the link below & book your meeting today! https://lnkd.in/gRexfGHw #CMCStrategy #Pharma #Biotech #Conference2024 #Innovation #ManufacturingExcellence #BPIEast 2024

🚀 New Blog Alert! 🚀 We’re excited to announce the release of GBI Bio's latest blog Titled: Innovation in Bispecific and Muti-Specific Antibody Engineering! Authored by our VP of BD: 🙋♂️ Robert Gustines In this blog, we dive into GBI Bio's manufacturing process of multi-specific monoclonal antibodies (mAbs), offering valuable insights and actionable tips to help you to understand the deeper focus from engineering to clone selection. Whether your program molecule is a multi-specific mAb or just looking to learn more about biotech manufacturing process, this blog has something valuable to discover! 👉 Check it out here: https://lnkd.in/eNxufUM7 💬 Have questions or thoughts? We’d love to hear your feedback in the comments! #NewBlog #IndustryInsights #Antibodies #CDMO #Biotech

🚨 New Whitepaper Alert! 🚨 I’m excited to announce that GBI Bio's latest whitepaper, has by published on Pharma's Almanac! 📄 We would like to give a special thank you to our authors: 🙋♀️ Natalia Bourguignon, Ph.D., Manager, MSAT-USP 🙋♂️ Joandiet Castaneda Padron, Senior Manager, MSAT 🙋♂️ Andrew Majdoch, VP of Technical Operations In this comprehensive guide our authors dive deep into DoE studies at GBI Bio, offering insights and actionable strategies to help develop process knowledge for challenges faced, when manufacturing biosimilars! 💡 What you’ll learn: - Objectives of DoE Approach - Methods Performed - Results of the DoE Studies Whether you're working with biosimilars or simply interested in biotech manufacturing, this whitepaper offers a fresh perspective backed by the latest data and expert analysis. 🔗 Click👇 to read your free copy: https://lnkd.in/e_puAwtk We'd love to hear your thoughts and feedback! Let’s keep the conversation going in the comments below! #Whitepaper #Research #IndustryInsights #ThoughtLeadership #NewPublication

🎯 New Blog Alert! 🎯 With the next big industry conference just around the corner, GBI Bio's Director of Business Development Nicholas Filipancic, MBA, has taken a deep dive into what we can expect this year. From cutting-edge tech showcases to game-changing keynote speakers, his latest blog covers it all! 👀 What’s Inside❔ - Efficiency Enhancements Across Bioprocessing Phases - Cell Line Development Breakthroughs - Emerging Technologies in Bioprocessing - CMC Considerations for Radiopharmaceutical Manufacturing Whether you're attending or just keeping tabs from afar, this guide will help you stay ahead of the curve. Click the link below to read the full blog and contact us/book a meeting to let us know what you think! 💡👇 https://lnkd.in/gJzaMjaE #Conference2024 #IndustryTrends #Innovation #Networking

  🌟 Celebrating the Heart of Our Industry on Labor Day 🌟 As a Contract Development & Manufacturing Organization, we know that every breakthrough in science, every product delivered, and every partnership forged is the result of hard work, dedication, and the passion of our incredible team. This Labor Day, we honor the talented professionals who make it all possible. From the lab to the production floor, your commitment to excellence drives us forward and empowers us to innovate and serve our partners better. Thank you to our employees, partners, and everyone in the industry who contributes to making a difference. Your continuous efforts not only fuel our success but also touch lives across the globe. Here’s to the hard work that fuels progress and the people who make it happen! #LaborDay #Teamwork #Innovation #CDMO #Manufacturing #LifeSciences #Gratitude

✨ We celebrated Labor Day with a fantastic team lunch, a small way to say thank you for the commitment and energy everyone brings to the table. Big thanks to everyone who brings their A-game every day – you’re the spark that keeps us shining ‼   #LaborDay #TeamSpirit #Gratitude#WorkCulture

📢 GBI Bio will be attending BioProcess International East 📢 This is a fantastic opportunity to connect with industry leaders, explore groundbreaking innovations, and engage in thought-provoking discussions that are shaping the future of biopharmaceutical development and production. 💭 Don't forget to book a meeting with the GBI Bio September 23rd to the 26th, in Boston, MA ‼ Representing Member Attending: 🙋♂️ Nicholas Filipancic, MBA, Director of Business Development For more information on the conference & to book a meeting with GBI Bio click the link below 👇 https://lnkd.in/eHWt_4cP #biologics #biotech #cdmo #BPIEast2024

📢 Exciting News ‼ 📚 GBI Bio is thrilled to share that our latest case study has been published by The Journal of Nuclear Medicine-JNM! 🎉 This publication dives deep into the complexities of antibody-chelator conjugates (ACCs), exploring innovative strategies and actionable insights that have applications in the Theranostics and other radio nuclide medical arenas. A huge thank you to our CSO, Muctarr Sesay, who authored this case study. Your dedication and expertise were instrumental in making this happen. 👏 If you're preparing your radioimmune conjugate program for clinical trials, this case study offers valuable lessons and practical takeaways that can help drive engineering your bioconjugate. Read the full case study via the link below 👇 🔗 https://lnkd.in/eQXrWJbd We look forward to hearing your thoughts and engaging in discussions on how we can continue to create solutions to the complexities of ACCs together! Feel free to contact us for CDMO services for Bioconjugation program! #CaseStudy #NewPublication #Innovation #Leadership